Grenke Valuation

Is GLJ undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

2/6

Valuation Score 2/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Earnings vs Peers

  • Price-To-Earnings vs Industry

  • Price-To-Earnings vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of GLJ when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: GLJ (€25.9) is trading below our estimate of fair value (€55.66)

Significantly Below Fair Value: GLJ is trading below fair value by more than 20%.


Key Valuation Metric

Which metric is best to use when looking at relative valuation for GLJ?

Other financial metrics that can be useful for relative valuation.

GLJ key valuation metrics and ratios. From Price to Earnings, Price to Sales and Price to Book to Price to Earnings Growth Ratio, Enterprise Value and EBITDA.
Key Statistics
Enterprise Value/Revenuen/a
Enterprise Value/EBITDAn/a
PEG Ratio0.6x

Price to Earnings Ratio vs Peers

How does GLJ's PE Ratio compare to its peers?

The above table shows the PE ratio for GLJ vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PEEstimated GrowthMarket Cap
Peer Average6.9x
8566 Ricoh Leasing Company
11.2xn/aJP¥153.4b
IF Banca IFIS
7.3x2.0%€1.2b
2666 Genertec Universal Medical Group
4.2x6.8%HK$9.4b
3877 CSSC (Hong Kong) Shipping
4.8x7.1%HK$10.3b
GLJ Grenke
13.4x23.4%€1.1b

Price-To-Earnings vs Peers: GLJ is expensive based on its Price-To-Earnings Ratio (13.4x) compared to the peer average (6.8x).


Price to Earnings Ratio vs Industry

How does GLJ's PE Ratio compare vs other companies in the European Diversified Financial Industry?

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a-6.6%
n/an/an/a
No. of CompaniesPE048121620

Fetching data

0 CompaniesPrice / EarningsEstimated GrowthMarket Cap
Industry Avg.n/a-6.6%
n/an/an/a
No more companies

Price-To-Earnings vs Industry: GLJ is expensive based on its Price-To-Earnings Ratio (13.4x) compared to the European Diversified Financial industry average (11.9x).


Price to Earnings Ratio vs Fair Ratio

What is GLJ's PE Ratio compared to its Fair PE Ratio? This is the expected PE Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

GLJ PE Ratio vs Fair Ratio.
Fair Ratio
Current PE Ratio13.4x
Fair PE Ration/a

Price-To-Earnings vs Fair Ratio: Insufficient data to calculate GLJ's Price-To-Earnings Fair Ratio for valuation analysis.


Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

The above table shows the analyst GLJ forecast and predictions for the stock price in 12 month’s time.
DateShare PriceAverage 1Y Price TargetDispersionHighLow1Y Actual priceAnalysts
Current€25.90
€34.06
+31.5%
18.7%€45.00€27.30n/a5
Oct ’25€24.10
€34.06
+41.3%
18.7%€45.00€27.30n/a5
Sep ’25€25.75
€34.06
+32.3%
18.7%€45.00€27.30n/a5
Aug ’25€28.00
€34.06
+21.6%
18.7%€45.00€27.30n/a5
Jul ’25€21.00
€32.46
+54.6%
14.5%€40.00€27.30n/a5
Jun ’25€21.60
€32.46
+50.3%
14.5%€40.00€27.30n/a5
May ’25€21.95
€32.46
+47.9%
14.5%€40.00€27.30n/a5
Apr ’25€24.30
€32.46
+33.6%
14.5%€40.00€27.30n/a5
Mar ’25€22.60
€31.90
+41.2%
15.3%€38.50€24.00n/a5
Feb ’25€22.75
€31.90
+40.2%
15.3%€38.50€24.00n/a5
Jan ’25€24.95
€31.90
+27.9%
15.3%€38.50€24.00n/a5
Dec ’24€23.40
€31.90
+36.3%
15.3%€38.50€24.00n/a5
Nov ’24€20.40
€31.90
+56.4%
15.3%€38.50€24.00n/a5
Oct ’24€20.75
€32.50
+56.6%
14.8%€38.50€24.00€24.105
Sep ’24€23.55
€33.90
+43.9%
7.8%€38.50€31.00€25.755
Aug ’24€24.95
€34.20
+37.1%
9.3%€40.00€31.00€28.005
Jul ’24€26.70
€35.17
+31.7%
10.3%€40.00€31.00€21.006
Jun ’24€27.85
€35.17
+26.3%
10.3%€40.00€31.00€21.606
May ’24€32.40
€35.50
+9.6%
9.7%€40.00€32.00€21.956
Apr ’24€25.48
€35.50
+39.3%
9.7%€40.00€32.00€24.306
Mar ’24€30.12
€37.33
+23.9%
16.0%€50.00€32.00€22.606
Feb ’24€27.16
€37.33
+37.5%
16.0%€50.00€32.00€22.756
Jan ’24€19.60
€37.33
+90.5%
16.0%€50.00€32.00€24.956
Dec ’23€21.04
€37.33
+77.4%
16.0%€50.00€32.00€23.406
Nov ’23€20.80
€38.05
+82.9%
16.8%€50.00€32.00€20.406
Oct ’23€18.69
€38.05
+103.6%
16.8%€50.00€32.00€20.756

Analyst Forecast: Target price is more than 20% higher than the current share price, but analysts are not within a statistically confident range of agreement.


Discover undervalued companies